Abstract:Due to the absence of safe and effective carriers for in vivo delivery, the applications of small interference RNA (siRNA) in clinic for therapeutic purposes have been limited. In this study, a biodegradable amphiphilic tri-block copolymer (mPEG(2000)-PLA(3000)-b-R(15)) composed of monomethoxy poly(ethylene glycol), poly(d,l-lactide) and polyarginine was synthesized and further self-assembled to cationic polymeric nanomicelles for in vivo siRNA delivery, with an average diameter of 54.30 ± 3.48 nm and a zeta potential of approximately 34.8 ± 1.77 mV. The chemical structures of the copolymers were well characterized by (1)H NMR spectroscopy and FT-IR spectra. In vitro cytotoxicity and hemolysis assays demonstrated that the polymeric nanomicelles showed greater cell viability and haemocompatibility than those of polyethyleneimine (PEI) or R(15) peptide. In vitro experiments demonstrated that EGFR targeted siRNA formulated in micelleplexes exhibited approximately 65% inhibition of EGFR expression on MCF-7 cells in a sequence-specific manner, which was comparable to Lipofectamine™ 2000. The results of intravenous administration showed Micelleplex/EGFR-siRNA significantly inhibited tumor growth in nude mice xenografted MCF-7 tumors, with a remarkable inhibition of EGFR expression. Furthermore, no positive activation of the innate immune responses and no significant body weight loss was observed during treatment suggested that this polymeric micelle delivery system is non-toxic. In conclusion, the present nanomicelles based on cationic mPEG(2000)-PLA(3000)-b-R(15) copolymer would be a safe and efficient nanocarrier for in vivo delivery of therapeutic siRNA.

Drug Delivery: Lipid‐Modified Aminoglycoside Derivatives for in Vivo Sirna Delivery (adv. Mater. 33/2013)

Lipid-Modified Aminoglycoside Derivatives for in Vivo Sirna Delivery

Novel Lipoidal Amine-Based Nanocarrier Formulations for Sirna Delivery

Lipid‐based nanotherapeutics for siRNA delivery

Sticky Nanoparticles: A Platform for Sirna Delivery by a Bis(zinc(II) Dipicolylamine)‐functionalized, Self‐Assembled Nanoconjugate

Lipid-Based Nanoparticles in the Systemic Delivery of Sirna

Multifunctional, Self-Assembling Anionic Peptide-Lipid Nanocomplexes for Targeted Sirna Delivery.

Self-assembly Nanomicelles Based on Cationic Mpeg-Pla-b-polyarginine(r15) Triblock Copolymer for Sirna Delivery.

Quantum Dot-Amphipol Nanocomplex for Intracellular Delivery and Real-Time Imaging of Sirna

Assembly Strategy of Liposome and Polymer Systems for Sirna Delivery.

Ionizable Amphiphilic Dendrimer-Based Nanomaterials with Alkyl-Chain-Substituted Amines for Tunable Sirna Delivery to the Liver Endothelium in Vivo

Polymeric‐Micelle‐Based Nanomedicine for Sirna Delivery

Differentially Charged Hollow Core/Shell Lipid–Polymer–Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery

Shell-Detachable Nanoparticles Based on A Light-Responsive Amphiphile for Enhanced Sirna Delivery

Porous Silicon Microparticles for Delivery of Sirna Therapeutics

Enhancing siRNA delivery by employing lipid nanoparticles

Adaptive Amphiphilic Dendrimer‐Based Nanoassemblies As Robust and Versatile Sirna Delivery Systems

Amphiphilic Polyallylamine Based Polymeric Micelles for Sirna Delivery to the Gastrointestinal Tract: in Vitro Investigations

Lipopeptide Nanoparticles for Potent and Selective Sirna Delivery in Rodents and Nonhuman Primates.

Hybrid Lipid–polymer Nanoparticles for Sustained Sirna Delivery and Gene Silencing

Amphiphilic Peptide Dendrimer-Based Nanovehicles for Safe and Effective Sirna Delivery